Researchers are using an advanced brain imaging method called MEG to understand why Parkinson’s drug levodopa doesn’t work ...

Simon Fraser University researchers are pioneering personalized Parkinson's treatment using MEG imaging. They discovered that ...

Researchers have used magnetoencephalography brain imaging technology to determine how the drug levodopa, the main drug used ...

Sidebar Key Issues. In fluctuating Parkinson's disease (PD) patients, treatment of PD using the catechol-O-methyl transferase inhibitor entacapone with carbidopa/levodopa improves quality of life ...

In doing so, the use of organoid models will be expanded across the US in Parkinson’s disease research. Currently dopamine replacement medications, like levodopa and dopamine agonists, are the primary ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

Background A 48-year-old man with a 9-year history of Parkinson's disease who had previously shown a good response to levodopa presented for evaluation of increasingly disabling motor fluctuations ...

Roche and Prothena are advancing Prasinezumab to Phase 3 for Parkinson’s despite mixed Phase 2 results. Click here to read an ...

Simon Fraser University Researchers are using an advanced brain imaging method called MEG to understand why Parkinson's drug ...

Abstract Abstract. Levodopa is the most efficacious agent for the treatment of motor features of Parkinson's disease but its chronic use is associated with the development of motor complications.